PeptidesDNA

Genetics & DNA

15 articles with genetic insights and evidence-tiered analysis.

12 minJul 23, 2026

5 Myostatin and Follistatin Variants That Predict Whether Peptides Build Muscle for You

Some people gain lean mass on every peptide protocol. Others barely respond. The difference is usually genetic. Here are the 5 variants that control your myostatin response and what each type should stack.

12 minJul 22, 2026

5 Genes That Predict Tendon Healing Speed: COL5A1, MMP3, and the Right Peptide for Each

Why do two people run the same BPC-157 protocol and one heals in 8 weeks while the other stalls at 20? Five genetic variants explain most of the gap. Here is how to find yours.

12 minJul 20, 2026

Why Nootropic Peptides Cause Brain Fog in 1 in 4 Users: The COMT, BDNF, and MTHFR Answer

One in four Semax users get brain fog instead of clarity. Three variants are associated with it: COMT, BDNF Val66Met and MTHFR. Here is how to know which group you are in before you dose.

12 minJul 19, 2026

Why Your IGF-1 Won't Go Up on Ipamorelin: The STAT5B Gene Nobody Talks About

IGF-1 flat despite a clean GH spike on ipamorelin or MK-677? STAT5B is the liver gene that converts your GH pulse into IGF-1 -- and partial variants silently block the translation.

11 minJul 13, 2026

Ipamorelin Not Working? The GHSR Gene Variant That Explains Every Non-Responder Case

Ipamorelin is hitting your receptor and your GH spike is real. But the GHSR variant nobody tests for is silencing the 50% of your GH signal that runs between injections.

11 minJul 11, 2026

GHR Exon 3 Deletion: The Gene That Predicts Your Growth Peptide IGF-1 Response

Why does your IGF-1 barely move on ipamorelin while someone else's jumps 80 points on the same dose? The GHR Exon 3 deletion explains more of that gap than protocol ever does.

11 minJul 8, 2026

Why Two People on the Same Ipamorelin Protocol Get Completely Different IGF-1 Results

If your IGF-1 barely moved on ipamorelin, it is probably not the dose. Two genetic variables explain 43% of why growth peptide IGF-1 response varies up to 3-fold between users.

12 minJun 27, 2026

MTHFR Brain Fog Still There? Nootropic Peptides That Work Downstream of the Broken Enzyme

Methylfolate works for some MTHFR carriers. For the rest, elevated homocysteine keeps suppressing BDNF no matter how much B9 you take. Semax changes the equation entirely.

11 minJun 22, 2026

Semaglutide vs Tirzepatide: Which Actually Works Better Based on Your GLP-1 Receptor Gene?

Why does tirzepatide produce 20% weight loss while semaglutide delivers 5% for the same patient? GLP1R and GIPR variants relate to both receptor pathways. 2026 data inside.

12 minJun 17, 2026

Akkermansia Gut Repair: Why Your Genetics Decide If It Works

Akkermansia is sold as a gut-repair supplement, but it does not patch your gut wall itself. Whether it can colonise you at all comes down partly to the genes that build the mucus it eats. Here is what the research actually shows.

12 minJun 12, 2026

Do Peptides Work After 50? How Your Aging Genes Change the Math

Do peptides work after 50? Yes, but the rules change. Three inherited differences decide which deficit is biggest for you, and therefore which peptide is worth buying first.

14 minJun 9, 2026

APOE4 Carrier? 7 Neuroprotective Peptides Ranked by Evidence

APOE4 triples your Alzheimer's risk and suppresses BDNF by 30 percent. But it makes you a better responder to Cerebrolysin. Seven peptides ranked by APOE4 failure mode.

10 minMay 28, 2026

Semaglutide Non-Responders: The Gene Behind the Gap

A 27,885-person study found the gene that predicts who loses weight fast on semaglutide and who barely moves. Your DNA already has the answer.

11 minMay 26, 2026

What Your 23andMe Data Can Actually Tell You About Peptides

Your 23andMe raw file is a survey of 650,000 known variants. Here is which peptide-response SNPs it reliably genotypes, what gaps exist across chip versions, and why the data is more useful than most realize.

16 minApr 17, 2026

Semaglutide and Your Genetics: Why Ozempic Works Differently for Everyone

10-17% of semaglutide users are non-responders. New genetic research — including a 27,885-person GWAS from 23andMe — reveals why. Your GLP1R, TCF7L2, and ARRB1 variants determine whether you'll lose 15% of your body weight or barely notice a difference.

Buy safe peptides